@sara-cm.bsky.social
Reposted
💡 #MWClinicalTips
📢 IMvigor011 trial: ctDNA-guided adjuvant immunotherapy in MIBC. Natera & Genentech/Roche
✅ Signatera-positive pts + atezolizumab → significant ↑ DFS & OS
✅ Signatera-negative pts → excellent outcomes w/out adjuvant Rx
📢 IMvigor011 trial: ctDNA-guided adjuvant immunotherapy in MIBC. Natera & Genentech/Roche
✅ Signatera-positive pts + atezolizumab → significant ↑ DFS & OS
✅ Signatera-negative pts → excellent outcomes w/out adjuvant Rx
August 19, 2025 at 2:33 PM
💡 #MWClinicalTips
📢 IMvigor011 trial: ctDNA-guided adjuvant immunotherapy in MIBC. Natera & Genentech/Roche
✅ Signatera-positive pts + atezolizumab → significant ↑ DFS & OS
✅ Signatera-negative pts → excellent outcomes w/out adjuvant Rx
📢 IMvigor011 trial: ctDNA-guided adjuvant immunotherapy in MIBC. Natera & Genentech/Roche
✅ Signatera-positive pts + atezolizumab → significant ↑ DFS & OS
✅ Signatera-negative pts → excellent outcomes w/out adjuvant Rx